Opening Microbiota Studies of Neurodegeneration and Stroke
Microbiota Studies of Neurodegeneration and Stroke
- Length
- 1 h 14 min
- Level
- Research
- Recorded
- University of Louisville2023
Chapter 1 of 7: Background and critique of Alzheimer immunotherapy
Traces how gut bacterial amyloid triggers protein misfolding and neurodegeneration across the brain.
Microbiota studies of neurodegeneration and stroke examine how gut bacteria influence neurological diseases through prion-like misfolding and inflammation. Robert Friedland reviews evidence that bacterial amyloid proteins like curli promote protein aggregation in conditions such as Alzheimer's, Parkinson's, and ALS. The talk analyzes animal models and dietary interventions, including polyphenols and fecal microbiota transplants, to target the gut-brain axis. Furthermore, the discussion questions current amyloid-targeting monoclonal antibodies and critiques traditional laboratory models for failing to replicate human clinical conditions.
Microbiota studies of neurodegeneration and stroke examine how gut bacteria influence neurological diseases through prion-like misfolding and inflammation. Robert Friedland reviews evidence that bacterial amyloid proteins like curli promote protein aggregation in conditions such as Alzheimer's, Parkinson's, and ALS. The talk analyzes animal models and dietary interventions, including polyphenols and fecal microbiota transplants, to target the gut-brain axis. Furthermore, the discussion questions current amyloid-targeting monoclonal antibodies and critiques traditional laboratory models for failing to replicate human clinical conditions.
Unaging: The Four Factors that Impact How You Age
120 Lessons in Critical Thinking for Young Doctors
Friedland, Journal of Alzheimer's Disease, 2015
Scientific Reports, 2016
Wang et al, PNAS 2021
Journal of Cerebral Blood Flow & Metabolism, 2020

This lecture
Talk 49 of 115 of UofL Neurology Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Microbiota in cerebrovascular disease: A key player and future therapeutic target
Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS
Drosophila as a model for microbiota study of neurodegeneration
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
There is already evidence that FMTs in adult humans are feasible, scalable, and safe
Sex-specific effects of microbiome perturbations on cerebral A beta amyloidosis and microglia phenotypes
In vitro and in vivo evidence for FUBA enhancement of amyloid production
Wu et al 2014
Stenvang et al 2016
Dirt Is Good